AQST - Balance Sheet - Aquestive Therapeutics, Inc.

Current Liabilities	18.9 M
Accounts Payable	10.3 M
Short-Term Debt	536 K
Other Current Liabilities	8.04 M
Non-Current Liabilities	143 M
Long-Term Debt	32.5 M
Other Non-Current Liabilities	110 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016
ASSETS
Cash & Cash Equivalents	71.5	23.9	27.3	28.0	31.8	49.3	60.6	17.4	9.2
Short Term Investments	0	0	0	0	0	0	0	0	0
Receivables	7.3	8.5	4.7	12.1	7.0	13.1	6.5	6.2	10.8
Inventory	6.0	6.8	5.8	4.0	2.5	2.9	5.4	4.0	2.9
Other Current Assets	3.3	1.9	2.1	6.2	6.8	6.0	3.4	0.6	0.4
Total Current Assets	88.2	41.0	39.9	47.3	44.6	68.3	74.2	28.2	23.3
PP&E	9.0	9.7	7.9	7.8	10.3	9.7	12.2	13.5	15.1
Intangible Assets	0	1.3	1.4	51 K	0.1	0.2	0.2	0.3	0.3
Goodwill	0	0	0	0	0	0.3	0	0	0
Long Term Investments	0	0	5.0	6.0	7.0	0	0	0	0
Other Long Term Assets	4.2	5.4	6.5	6.9	7.8	0	0.2	1.2	0.6
Other Assets	0	0	0	0	0	0	0	0	0
Total Assets	101.4	57.4	55.7	62.0	62.9	78.5	86.9	43.1	39.4
LIABILITIES
Accounts Payable	10.3	8.9	9.9	8.3	7.1	12.3	20.4	9.6	6.6
Short Term Debt	0.5	0.4	19.0	2.9	3.3	0	4.6	0	0
Other Current Liabilities	6.6	7.1	8.8	9.6	9.7	5.2	4.3	4.1	3.4
Total Current Liabilities	18.9	18.3	39.7	22.0	21.1	18.6	33.0	15.3	10.8
Long Term Debt	32.5	32.9	102.6	112.6	84.7	60.3	42.6	45.5	38.6
Deferred Tax Income	0	0	0	59.1	47.5	0	0	0	0
Other Liabilities	110.2	80.3	2.0	2.5	1.9	1.4	1.2	8.8	7.5
Total Liabilities	161.6	163.9	174.2	144.1	111.4	84.6	76.8	69.6	57.0
EQUITY
Common Stock	91 K	69 K	55 K	41 K	35 K	34 K	25 K	12.7	11.2
Retained Earnings	(363.2)	(319.1)	(311.2)	(256.8)	(186.3)	(130.5)	(61.4)	(120.1)	(108.7)
Other Accumulative Comprehensive Income/Loss	0	0	0	0	0	0	(35.2)	(32.0)	(28.3)
Total Equity	(60.2)	(106.5)	(118.6)	(82.1)	(48.5)	(6.1)	10.1	(26.5)	(17.6)
Total Liabilities and Equity	101.4	57.4	55.7	62.0	62.9	78.5	86.9	43.1	39.4
SHARES OUTSTANDING
Common Shares Outstanding	86.7	61.3	48.7	38.1	33.7	25.4	20.7	20.0	24.5

Free